Advertisement

Ads Placeholder
Loading...

Grifols, S.A.

GIKLYPNK
Healthcare
Drug Manufacturers - General
$5.18
$0.00(0.00%)
U.S. Market is Open • 15:43

Grifols, S.A. (GIKLY) Stock Overview

Explore Grifols, S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap13.6B
P/E Ratio15.42
EPS (TTM)$0.32
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$5.18
3 Months$7.07
1 Year Target$7.07

GIKLY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Grifols, S.A. (GIKLY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 8.60, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $7.07.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.42 and a market capitalization of 13.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-19.69%
3-Month Change
-15.91%
6-Month Change
-27.45%
Year-to-Date (YTD) Change
-15.91%
1-Year Change
11.16%
3-Year Change
5.50%
5-Year Change
-61.63%
All-Time (Max) Change
31.14%

Contact Information

34 93 571 02 21
Avinguda de la Generalitat, 152, Barcelona, NaN, 08174

Company Facts

238,330 Employees
IPO DateJan 20, 2010
CountryES
Actively Trading

Frequently Asked Questions